A detailed history of Glass Jacobson Investment Advisors LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Glass Jacobson Investment Advisors LLC holds 2,651 shares of NVO stock, worth $285,327. This represents 0.14% of its overall portfolio holdings.

Number of Shares
2,651
Previous 3,211 17.44%
Holding current value
$285,327
Previous $412 Million 8.22%
% of portfolio
0.14%
Previous 0.15%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$122.71 - $146.91 $68,717 - $82,269
-560 Reduced 17.44%
2,651 $378 Million
Q4 2023

Jan 22, 2024

BUY
$87.78 - $105.45 $18,521 - $22,249
211 Added 7.03%
3,211 $332 Million
Q3 2023

Nov 07, 2023

BUY
$90.94 - $199.54 $180,061 - $395,089
1,980 Added 194.12%
3,000 $273 Million
Q2 2023

Jul 25, 2023

BUY
$155.98 - $172.65 $88,752 - $98,237
569 Added 126.16%
1,020 $165 Million
Q4 2022

Feb 06, 2023

BUY
$102.55 - $135.33 $46,250 - $61,033
451 New
451 $61 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $243B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Glass Jacobson Investment Advisors LLC Portfolio

Follow Glass Jacobson Investment Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Glass Jacobson Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Glass Jacobson Investment Advisors LLC with notifications on news.